Showing results (281-290 of 290) with videos related to

Sort By:
Pageof 29
You have reached the last page of results.This site can display upto 290 results.
The New England Journal of Medicine|June 27, 1996
Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study GroupC J Fisher, J M Agosti, S M Opal, et al.
JAMA|August 28, 1991
A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study GroupR L Greenman, R M Schein, M A Martin, et al.
Assistive Technology : the Official Journal of RESNA|June 18, 2019
Functional mobility assessment is reliable and correlated with satisfaction, independence and skillsDebora Caires Paulisso, Mark R Schmeler, Richard M Schein, et al.
Critical Care Medicine|March 1, 1993
Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study GroupC J Fisher, S M Opal, J F Dhainaut, et al.
Critical Care Medicine|March 11, 2003
Efficacy and safety of LY315920Na/S-5920, a selective inhibitor of 14-kDa group IIA secretory phospholipase A2, in patients with suspected sepsis and organ failureEdward Abraham, Chris Naum, Venkata Bandi, et al.
Critical Care Medicine|June 1, 1995
A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study GroupR C Bone, R A Balk, A M Fein, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|May 8, 2001
Granulocyte-colony stimulating factor in the prevention of postoperative infectious complications and sub-optimal recovery from operation in patients with colorectal cancer and increased preoperative risk (ASA 3 and 4). Protocol of a controlled clinical trial developed by consensus of an international study group. Part one: rationale and hypothesisW Lorenz, B Stinner, A Bauhofer, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|June 8, 2001
Granulocyte-colony stimulating factor in the prevention of postoperative infectious complications and sub-optimal recovery from operation in patients with colorectal cancer and increased preoperative risk (ASA 3 and 4). Protocol for a controlled clinical trial developed by consensus of an international study group. Part two: design of the studyA Bauhofer, W Lorenz, B Stinner, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|June 21, 2001
Granulocyte-colony stimulating factor in the prevention of postoperative infectious complications and sub-optimal recovery from operation in patients with colorectal cancer and increased preoperative risk (ASA 3 and 4). Protocol of a controlled clinical trial developed by consensus of an international study group. Part three: individual patient, complication algorithm and quality manageB Stinner, A Bauhofer, W Lorenz, et al.
The Journal of Infectious Diseases|September 1, 1996
Immunoprophylaxis against klebsiella and pseudomonas aeruginosa infections. The Federal Hyperimmune Immunoglobulin Trial Study GroupS T Donta, P Peduzzi, A S Cross, et al.
Pageof 29